The safety profile of imatinib in CML and GIST: long-term considerations von Thanopoulou, Eirini, Judson, Ian

Volltext

Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literat... von Thanopoulou, Eirini, Khader, Leila, Caira, Morena, Wardley, Andrew, Ettl, Johannes, Miglietta, Federica, Neven, Patrick, Guarneri, Valentina

Volltext

INAVO121: Phase III study of inavolisib (INAVO) + fulvestrant (FUL) vs. alpelisib (ALP) + FUL in patients (pts) with hormone receptor-positive, HER2-negative (HR+, HER2–) PIK3CA -m... von Juric, Dejan, Kalinsky, Kevin, Im, Seock-Ah, Ciruelos, Eva M, Bianchini, Giampaolo, Barrios, Carlos H., Jacot, William, Schmid, Peter, Loi, Sherene, Rugo, Hope S., Craine, Veronica, Hutchinson, Katherine E., Flechais, Aulde, Thanopoulou, Eirini, Harbeck, Nadia

Volltext

Pneumonitis and pulmonary fibrosis associated with breast cancer treatments von Omarini, Claudia, Thanopoulou, Eirini, Johnston, Stephen R. D.

Volltext

Abstract OT-36-01: Phase III study of GDC-0077 or placebo (pbo) with palbociclib (P) + fulvestrant (F) in patients with PIK3CA -mutant/hormone receptor-positive/HER2-negative local... von Turner, Nicolas, Jhaveri, Komal, Kalinsky, Kevin, Loibl, Sibylle, Loi, Sherene, Im, Seock-Ah, Saura, Cristina, Schmid, Peter, Schutzman, Jennifer L, Stout, Thomas J, Lei, Guiyuan, Hutchinson, Katherine E, Thanopoulou, Eirini, Juric, Dejan

Volltext

Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literat... von Thanopoulou, Eirini, Khader, Leila, Caira, Morena, Wardley, Andrew, Ettl, Johannes, Miglietta, Federica, Neven, Patrick, Guarneri, Valentina

Volltext

Tumour heterogeneity and immune-modulation von Jamal-Hanjani, Mariam, Thanopoulou, Eirini, Peggs, Karl S, Quezada, Sergio A, Swanton, Charles

Volltext

Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital von Thanopoulou, Eirini, Aleksic, Aleksandar, Thway, Khin, Khabra, Komel, Judson, Ian

Volltext

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors von Thanopoulou, Eirini, Thway, Khin, Khabra, Komel, Judson, Ian

Volltext

Patient/oncologist decisions about adjuvant chemotherapy in ER+ve, HER2-ve early breast cancer following endopredict testing von Bloomfield, David J, Arbon, Amy, Cox, Jane, Hack, Berkin, Hall, Julia, Harper-Wynne, Catherine, Hinde, Sebastian, Jenkins, Val, Mackay, James, Matthews, Lucy A, May, Shirley F, Moss, Adrian, Patel, Gargi Surendra, Simcock, Richard, Thanopoulou, Eirini, Westwell, Sarah, Wlaszly, Dominika, Fallowfield, Lesley

Volltext

Real-world experience of exemestane-everolimus (EXE-EVE) in elderly patients with hormone-receptor positive (HR+) metastatic breast cancer (MBC) von Redana, Stefania, Papadimitraki, Elisavet, Okonji, David Odhiambo, Khabra, Komel, Thanopoulou, Eirini, Chiramel, Jaseela, Papanastasopoulos, Panagiotis, Wardley, Andrew M., Hogg, Martin S., Howell, Sacha Jon, Zucchini, Giorgia, Kenny, Laura M., Ring, Alistair E., Johnston, Stephen R. D.

Volltext

Safety and efficacy of eribulin mesylate (EM) in patients with advanced breast cancer: The Royal Marsden experience von Thanopoulou, Eirini, Omarini, Claudia, Yeo, Belinda, Allen, Mark, Parton, Marina, Turner, Nicholas C., O'Brien, Mary E.R., Johnston, Stephen R. D., Smith, Ian E.

Volltext

The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer von Thanopoulou, Eirini, Kotzamanis, George, Pateras, Ioannis S., Ziras, Nicholaos, Papalambros, Alexandros, Mariolis-Sapsakos, Theodoros, Sigala, Fragiska, Johnson, Elizabeth, Kotsinas, Athanassios, Scorilas, Andreas, Gorgoulis, Vassilis G.

Volltext

New Approaches for Hormone-Receptor Positive Metastatic Breast Cancer von Thanopoulou, Eirini, Johnston, Stephen R. D.

Volltext

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von WARBURTON, Simon Peter, JOO, Stephanie Royer, SONG, Chunyan, SCHUTZMAN, Jennifer Lee, DEY, Anwesha, SONG, Kyung Wha, THANOPOULOU, Eirini

Volltext bestellen

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von WARBURTON, Simon Peter, JOO, Stephanie Royer, SONG, Chunyan, SCHUTZMAN, Jennifer Lee, DEY, Anwesha, SONG, Kyung Wha, THANOPOULOU, Eirini

Volltext bestellen

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von Warburton, Simon Peter, Joo, Stephanie Royer, Song, Chunyan, Thanopoulou, Eirini, Schutzman, Jennifer Lee, Song, Kyung Wha, Dey, Anwesha

Volltext bestellen

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von WARBURTON, Simon Peter, JOO, Stephanie Royer, SONG, Chunyan, SCHUTZMAN, Jennifer Lee, DEY, Anwesha, SONG, Kyung Wha, THANOPOULOU, Eirini

Volltext bestellen

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von JOO Stephanie Royer, SONG Kyung Wha, WARBURTON Simon Peter, DEY Anwesha, SCHUTZMAN Jennifer Lee, THANOPOULOU Eirini, SONG Chunyan

Volltext bestellen

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER von WARBURTON, Simon Peter, JOO, Stephanie Royer, SONG, Chunyan, SCHUTZMAN, Jennifer Lee, DEY, Anwesha, SONG, Kyung Wha, THANOPOULOU, Eirini

Volltext bestellen